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enzymes, COX-1, COX-2, cPGES and mPGES was demon-
strated in OA cartilage by positive immunostaining. IL-1 sig-
niﬁcantly augmented expression of COX-2 and mPGES in OA
cartilage. Treatment of OA cartilage/chondrocytes with PGE2
(0.1-10uM) resulted in the following dose dependent catabolic
effects with respect to aggrecan metabolism 1) inhibition of pro-
teoglycan synthesis (35S incorporation) by chondrocyte cultures
to levels of 75% of control (p<0.01), 2) augmentation of release
of aggrecan fragment CS846 epitope, 3) inhibition of aggrecan
gene expression and 4) induction of production of pro-MMP-13,
IL-6 and IL-8. The potency of PGE2 effects on PG synthesis
were comparable to that of IL-1b, and the inhibitory effects of
the combination of IL-1 and PGE2 (10uM) were additive. PGE2
augmentation of collagen degradation (C12C assay) could be
blocked by MMP inhibitor, Ilomastat (5uM) (p<0.05) in OA car-
tilage explant cultures. In OA chondrocytes, PGE2 inhibition by
celecoxib (2uM) treatment partially reversed IL-1 mediated in-
hibition of PG synthesis from 45% to 65% of control values
(p<0.01). Similarly, IL-1 mediated induction of aggrecanase 4
and 5 (ADAMTS) was also reversed by celecoxib treatment by
more than 60%. Interestingly, blocking of EP4 receptor, a known
receptor of PGE2, with EP4 antagonist (A23858) mimicked cele-
coxib, and inhibited ADAMTS 4 and 5 expressions as analyzed
by real time PCR.
Conclusions: Our results suggest that IL-1 mediated inhibition
of proteoglycan aggrecan expression and enhanced degradation
is, in part, mediated by prostaglandin E2 acting via the EP4
receptor.These ﬁndings underscore the importance of PGE2 as
a central mediator of OA pathogenesis.
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Purpose: Articular chondrocytes are surrounded by an extra-
cellular pool of ﬁbroblast growth factor (FGF)-2. The roles of
FGF-2 on aggrecan catabolism by aggrecanases; a disintegrin
and metalloproteinase with thrombospondin motifs (ADAMTS)-4
and -5 were investigated in human articular cartilage.
Methods: Normal human articular cartilages were stimulated
with IL-1α in the presence or absence of FGF-2. Aggrecan
catabolism was assessed by measuring the release of gly-
cosaminoglycan by DMMB and assayed by western blotting
with neo-epitope antibodies (ARGS and AGEG) which recog-
nize aggrecanase dependent aggrecan fragments. The expres-
sion of ADAMTS-4 and -5 were measured by RT-PCR. Matrix
metalloproteinase (MMP)-1, -3 and -13 and tissue inhibitor of
metalloproteinases (TIMP)-1 and 3 production was measured
by western blotting. Interleukin (IL)-6 and -8 were measured by
ELISA. Proteoglycan synthesis was monitored by incorporation
of 35S labelled sulphate incorporation.
Results: IL-1α caused cleavage of aggrecan in cultured human
articular cartilage explants, with release of aggrecan fragments
containing ARGS and AGEG neo-epitopes. These were inhibited
by exogenous FGF-2 (1-100 ng/ml). TNFα and retinoic acid also
stimulated release of neo-epitope bearing fragments and this was
also suppressed by FGF-2. IL-1α induced mRNA for ADAMTS-4
and ADAMTS-5 in cartilage explants and isolated chondrocytes.
FGF-2 inhibited the IL-1α-induced increase in both ADAMTS-
4 and ADAMTS-5 mRNA. IL-1α-induced aggrecan degradation
was inhibited by exogenous TIMP-1 as well as N-terminal TIMP-
3, although FGF-2 did not affect their production when IL-1α was
present. FGF-2 did not prevent IL-1α suppression of proteoglycan
synthesis nor its ability to stimulate the production of IL-6, -8,
MMP-1, -3 and -13.
Conclusions: Our ﬁndings suggest that FGF-2 may play a
chondroprotective role in human articular cartilage by controlling
the expression of the aggrecanase, ADAMTS-4 and ADAMTS-5.
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Purpose: IGF-I and OP-1 have been shown to inhibit IL-1β stim-
ulation of chondrocyte MMP expression. IL-1 signaling requires
activation of the p38 MAP kinase. Four different isoforms of p38
have been previously described (alpha, beta, gamma, and delta)
but their function has not been deﬁned in chondrocytes. The
aim of this study was to determine which p38 isoforms mediate
chondrocyte IL-1 signaling and determine if they are inhibited by
the growth factor combination of IGF-I and OP-1.
Methods: Human articular chondrocytes were isolated by enzy-
matic digestion of normal cartilage obtained from tissue donors
and OA cartilage removed during joint replacement. Cells were
cultured in DMEM/F12 with 10% serum to conﬂuency and them
made serum-free for stimulation studies. Speciﬁc p38 isoform
expression was detected by Western blotting of protein lysates
using p38 isoform speciﬁc antibodies and RT-PCR of RNA prepa-
rations using p38 isoform speciﬁc primers. Cytosol and nuclear
preparations were made using a commercially available kit to
detect p38 translocation to the nucleus after cytokine stimulation.
Results: RT-PCR and Western blotting showed that p38α and
p38γ were the most highly expressed p38 isoforms in chondro-
cytes. Western Blotting using a phospho-speciﬁc p38 antibody
(that recognizes all four p38 isoforms) after IL-1 stimulation
of chondrocytes revealed the presence of two bands. Based
on molecular weight and previous studies, we conﬁrmed that
one band was p38α. We used 2-D gel electrophoresis to also
conﬁrm that IL-1 stimulated phosphorylation of p38γ. Translo-
cation experiments revealed a shift of phosphorylated p38 to
the nucleus after IL-1 stimulation. This phosphorylated p38 was
determined to be p38α, as this isoform was shown to be present
in the nucleus whereas p38γ could not be detected in the nu-
clear preparations. The combination of IGF-1 and OP-1, added
30 minutes prior to IL-1 stimulation, inhibited IL-1 induced p38
phosphorylation as well as IL-1 induced phosphorylation of ATF-
2 and MAPKAPK-2, two signaling molecules directly downstream
of p38α but not p38γ.
Conclusions: These results are, to our knowledge, the ﬁrst
to demonstrate IL-1 phosphorylation of two p38 isoforms (al-
pha and gamma) in chondrocytes. Although phosphorylation of
both isoforms was stimulated by IL-1 and phosphorylation of
p38α was inhibited by IGF-I+OP-1, it appeared that p38α me-
diates its effects at the level of gene transcription. p38α but
not p38γ was found to translocate to the nucleus and the p38α
substrates ATF-2 and MAPKAPK-2 were both phosphorylated.
Further experiments are needed to determine the role of p38γ in
chondrocyte signaling.
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Purpose: Reactive oxygen species (ROS) act as secondary
messengers in signaling cascades activated in response to extra-
